Similar articles

• Possibility of immunotherapy for biliary tract cancer: how do we prove efficacy? Introduction to a current ongoing phase I and randomized phase II study to evaluate the efficacy and safety of adding Wilms tumor 1 peptide vaccine to gemcitabine and cisplatin for the treatment of advanced biliary tract cancer (WT-BT trial).

  Okusaka T, Ueno M, Sato T, Heike Y. Okusaka T, et al. J Hepatobiliary Pancreat Sci. 2012 Jul;19(4):314-8. doi: 10.1007/s00534-011-0495-1. J Hepatobiliary Pancreat Sci. 2012. PMID: 22273718 Clinical Trial.
• [Systemic chemotherapy with gemcitabine for advanced biliary tract carcinoma].

  Nakamura N, Teramoto K, Arii S. Nakamura N, et al. Nihon Rinsho. 2006 Jan;64 Suppl 1:534-8. Nihon Rinsho. 2006. PMID: 16457320 Review. Japanese. No abstract available.
• Phase I trial of S-1 every other day in combination with gemcitabine/cisplatin for inoperable biliary tract cancer.

  Uwagawa T, Sakamoto T, Abe K, Okui N, Hata D, Shiba H, Futagawa Y, Aiba K, Yanaga K. Uwagawa T, et al. Cancer Chemother Pharmacol. 2015 Jan;75(1):191-6. doi: 10.1007/s00280-014-2636-0. Epub 2014 Nov 25. Cancer Chemother Pharmacol. 2015. PMID: 25422155 Clinical Trial.
• A step forward in the treatment of advanced biliary tract cancer.

  Wolpin BM, Mayer RJ. Wolpin BM, et al. N Engl J Med. 2010 Apr 8;362(14):1335-7. doi: 10.1056/NEJMe1001183. N Engl J Med. 2010. PMID: 20375411 No abstract available.
• Chemotherapy for biliary tract cancer in Japan.

  Okusaka T. Okusaka T. Semin Oncol. 2002 Dec;29(6 Suppl 20):51-3. doi: 10.1053/sonc.2002.37377. Semin Oncol. 2002. PMID: 12577234 Review.